Mogens Holst Nissen

Mogens Holst Nissen

Professor

Member of:

    ORCID: 0000-0001-7729-8667

    Publication year:
    All
    111 - 120 out of 125Page size: 10
    1. 1990
    2. Published

      Neutrophil beta-2 microglobulin: an inflammatory mediator.

      Bjerrum, O. W., Nissen, Mogens Holst & Borregaard, N., 1990, In: Scandinavian Journal of Immunology. 32, 3, p. 233-42 9 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Proteolysis of the heavy chain of major histocompatibility complex class I antigens by complement component C1s.

      Eriksson, H. & Nissen, Mogens Holst, 1990, In: BBA General Subjects. 1037, 2, p. 209-15 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. 1987
    5. Published

      Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.

      Nissen, Mogens Holst, Larsen, J. K., Plesner, T., Olesen, B. K. & Ernst, P., 1987, In: Clinical and Experimental Immunology. 69, 3, p. 632-8 6 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease.

      Nissen, Mogens Holst, Bjerrum, Ole Jannik, Plesner, T., Wilken, M. & Rørth, M., 1987, In: Clinical and Experimental Immunology. 67, 2, p. 425-32 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Proteolytically modified human beta 2-microglobulin augments the specific cytotoxic activity in murine mixed lymphocyte culture.

      Nissen, Mogens Holst & Claesson, Mogens Helweg, 1987, In: Journal of Immunology. 139, 4, p. 1022-9 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    8. Published

      Purification and biochemical characterization of the complete structure of a proteolytically modified beta-2-microglobulin with biological activity.

      Nissen, Mogens Holst, Thim, L. & Christensen, M., 1987, In: European Journal of Biochemistry. 163, 1, p. 21-8 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    9. Published

      Recombinant interferon A (IFL-rA) therapy of small cell and squamous cell carcinoma of the lung. A phase II study.

      Olesen, B. K., Ernst, P., Nissen, Mogens Holst & Hansen, H. H., 1987, In: European journal of cancer & clinical oncology. 23, 7, p. 987-9 2 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    10. 1985
    11. Published

      Beta-2-microglobulin excretion: an indicator of long term nephrotoxicity during cis-platinum treatment?

      Sørensen, P. G., Nissen, Mogens Holst, Groth, S. & Rørth, M., 1985, In: Cancer Chemotherapy and Pharmacology. 14, 3, p. 247-9 2 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    12. Published

      Creatine kinase BB and beta-2-microglobulin as markers of CNS metastases in patients with small-cell lung cancer.

      Pedersen, A. G., Bach, F. W., Nissen, Mogens Holst & Bach, F., 1985, In: Journal of Clinical Oncology. 3, 10, p. 1364-72 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    13. Published

      Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.

      Nissen, Mogens Holst, Plesner, T., Larsen, J. K., Olesen, B. K. & Ernst, P., 1985, In: Clinical and Experimental Immunology. 59, 2, p. 327-35 8 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    Previous 1...8 9 10 11 12 13 Next

    ID: 7594